Mercer Global Advisors
EW icon

Mercer Global Advisors’s Edwards Lifesciences EW Stock Holding History

Mercer Global Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3M Buy
279,851
+19,134
+7% +$1.6M 0.03% 303
2026
Q1 		$20.9M Buy
260,717
+8,984
+4% +$741K 0.03% 308
2025
Q4 		$21.5M Buy
251,733
+29,765
+13% +$2.44M 0.03% 320
2025
Q3 		$17.3M Buy
221,968
+117,331
+112% +$9.17M 0.03% 348
2025
Q2 		$8.18M Sell
104,637
-18,522
-15% -$1.38M 0.02% 440
2025
Q1 		$8.93M Buy
123,159
+1,774
+1% +$127K 0.02% 389
2024
Q4 		$8.99M Buy
+121,385
New +$8.5M 0.02% 381
2024
Q1 		– Sell
-52,934
Closed -$4.04M – 2061
2023
Q4 		$4.04M Sell
52,934
-2,718
-5% -$189K 0.01% 533
2023
Q3 		$3.86M Buy
+55,652
New +$4.47M 0.01% 508
2023
Q1 		– Sell
-43,881
Closed -$3.27M – 1970
2022
Q4 		$3.27M Sell
43,881
-3,837
-8% -$296K 0.02% 550
2022
Q3 		$3.94M Sell
47,718
-1,643
-3% -$158K 0.02% 445
2022
Q2 		$4.69M Buy
49,361
+1,306
+3% +$135K 0.03% 387
2022
Q1 		$5.66M Buy
48,055
+6,728
+16% +$755K 0.03% 354
2021
Q4 		$5.35M Buy
41,327
+2,584
+7% +$301K 0.03% 356
2021
Q3 		$4.39M Sell
38,743
-3,229
-8% -$369K 0.03% 379
2021
Q2 		$4.35M Sell
41,972
-862
-2% -$81.3K 0.03% 354
2021
Q1 		$3.58M Sell
42,834
-2,884
-6% -$244K 0.03% 374
2020
Q4 		$4.17M Buy
45,718
+12,602
+38% +$1.05M 0.05% 256
2020
Q3 		$2.64M Buy
33,116
+1,072
+3% +$83.6K 0.04% 314
2020
Q2 		$2.21M Buy
32,044
+9,364
+41% +$665K 0.04% 310
2020
Q1 		$1.43M Buy
22,680
+11,748
+107% +$847K 0.03% 381
2019
Q4 		$850K Sell
10,932
-594
-5% -$46.4K 0.02% 564
2019
Q3 		$844K Sell
11,526
-264
-2% -$18.5K 0.02% 536
2019
Q2 		$726K Sell
11,790
-3,606
-23% -$218K 0.02% 560
2019
Q1 		$982K Buy
+15,396
New +$879K 0.04% 421

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Mercer Global Advisors's EW Position: Q2 2026 in Review

Mercer Global Advisors increased its Edwards Lifesciences (EW) stake by 7.3% in Q2 2026, buying an estimated $1.6M and bringing the position to 279,851 shares worth $25.3M. The position accounts for 0.03% of the portfolio, ranked #303.

Mercer Global Advisors first reported a position in EW in Q1 2019 and has held it in 25 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Mercer Global Advisors held 279,851 shares of Edwards Lifesciences worth $25.3M as of Q2 2026.
  • Mercer Global Advisors bought 19,134 Edwards Lifesciences shares in Q2 2026, an estimated $1.6M.
  • Edwards Lifesciences made up 0.03% of Mercer Global Advisors's portfolio in Q2 2026, its #303 holding.
  • Mercer Global Advisors first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 25 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.